Most patients experience these symptoms as mild to moderate in severity, with a relatively small percentage discontinuing treatment due to gastrointestinal effects
The body often adjusts to the medication over several weeks, though individual experiences vary
Choosing between Semaglutide and Tirzepatide depends on your health history, weight loss goals, and tolerance to medication
Some patients experience mild queasiness after meals, while others report moderate nausea that interferes with daily activities
Early communication helps adjust your dosage and prevent unnecessary discomfort
GLP-1 medications, such as Semaglutide and Tirzepatide, target these underlying pathways by enhancing satiety signals and improving insulin response, allowing the body to sustain weight reduction without severe deprivation